Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine with propofol for prevention of nausea, vomiting, and pain after endoscopy
IRCT20250527065940N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in postoperative nausea and vomiting (PONV) and acute pain comparing Propofol + lidocaine with Propofol alone (2 arms). Primary endpoints: Nausea, Vomiting and 2 more. Started Jun 2025; status: completed.
02
Drugs
lidocainepropofol
03
Conditions
postoperative nausea and vomiting (PONV)acute pain
Beyond the preview
Go deeper on IRCT20250527065940N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250527065940N1.